IDF21-0653 Exploring different ways to predict mortality in a cost-effectiveness model for obesity von Lopes, S., Grand, T., Johansen, P., Lamotte, M., Olivieri, A.V.

Volltext

EE277 Assessing the Cost-Effectiveness of Semaglutide 2.4 Mg Injection for Chronic Weight Management in Portugal von Borges, M., Soares, M., Lamotte, M., Olivieri, A.V., Shukla, S., Freitas, P., Silva Miguel, L.

Volltext

PDB30 COMPARABILITY OF RESULTS USING TWO ALTERNATIVE VERSIONS OF THE IQVIA CORE DIABETES MODEL von Gurjar, K., Ramos, M., Monteiro, S., Olivieri, A.V., Altrabsheh, E., Lamotte, M.

Volltext

PDB64 ASSOCIATION BETWEEN CARDIOVASCULAR DISEASE RISK FACTORS AND HYPOGLYCAEMIC EVENTS IN TYPE 2 DIABETES USING THE IQVIA CORE DIABETES MODEL von Altrabsheh, E., Monteiro, S., Ramos, M., Gurjar, K., Olivieri, A.V., Lamotte, M.

Volltext

PDB23 BODY MASS INDEX ASSOCIATED UTILITY APPROACHES IN THE IQVIA CORE DIABETES MODEL von Ramos, M., Altrabsheh, E., Monteiro, S., Olivieri, A.V., Gurjar, K., Lamotte, M.

Volltext

PDB35 CONTRASTING FRAMINGHAM RISK EQUATIONS IN TYPE 2 DIABETES USING THE IQVIA CORE DIABETES MODEL von Monteiro, S., Ramos, M., Altrabsheh, E., Gurjar, K., Olivieri, A.V., Lamotte, M.

Volltext

PDB26 CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL von Olivieri, A.V., Ramos, M., Altrabsheh, E., Monteiro, S., Gurjar, K., Lamotte, M.

Volltext

Analysis of intercellular washing fluids of potato tubers and detection of increased proteolytic activity upon fungal infection von Olivieri, F, Godoy, A.V. (Nacional Univ. de Mar del Plata (Argentina))

Volltext

Iron Chelation with Oral Deferiprone in Patients with Thalassemia von Tricta, F, Spino, M

Volltext

Arthropathy in thalassaemia patients receiving deferiprone von Al-Refaie, F.N., Wonke, B., Hoffbrand, A.V., Olivieri, NancyF

Volltext